Ingevity (NGVT) Research & Development (2016 - 2026)

Ingevity (NGVT) has reported Research & Development for 11 consecutive years, with $6.1 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Research & Development fell 12.86% year-over-year to $6.1 million in Q2 2026; TTM through Jun 2026 was $27.2 million, a 1.87% increase from a year earlier, with the FY2025 full-year figure at $28.4 million, up 15.92% from the prior year.
• Research & Development was $6.1 million for Q2 2026 at Ingevity, down from $6.7 million in the prior quarter.
• Over five years, Research & Development peaked at $8.8 million in Q1 2023 and troughed at $800000.0 in Q4 2023.
• A 5-year average of $6.9 million and a median of $7.1 million in 2022 frame the typical range for Research & Development.
• Across the five-year window, Research & Development tumbled 88.89% in 2023 and surged 712.5% in 2024, its largest moves.
• Over 5 years, Research & Development stood at $7.2 million in 2022, then plunged by 88.89% to $800000.0 in 2023, then surged by 712.5% to $6.5 million in 2024, then advanced by 13.85% to $7.4 million in 2025, then declined by 17.57% to $6.1 million in 2026.
• The last three Research & Development figures came in at $6.1 million (Q2 2026), $6.7 million (Q1 2026), and $7.4 million (Q4 2025), per Business Quant data.